155.84 USD
↗ 2.27 (1.48%)LIVE (AS OF 12:17 PM EDT)
Gilead Sciences Inc
GILDNASDAQ • USD
Market: OPEN
Gilead Sciences Inc (GILD) trades at $155.84 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place GILD at a fair price relative to peers.
Technical & fundamental data as of Oct 21, 2026.
Open?$154.24
High?$156.47
Low?$153.25
Prev. Close?$153.57
Volume?2.2M
Avg. Volume?6.0M
VWAP?$155.57
Rel. Volume?0.37x
Bid / Ask
Bid?$148.51 × 200
Ask?$155.66 × 100
Spread?$7.15
Midpoint?$152.08
Valuation & Ratios
Market Cap?190.4B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?16.10
EPS?-$2.61
Dividend?2.14%
Ex-Dividend?N/A
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Themes
Employees
17.0K
Market Cap
190.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
FOSTER CITY, CA 94404
Phone: (650) 574-3000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?86
Momentum?33
Short Sent.?48
Piotroski F-Score?3/9Weak
Altman Z-Score?3.62Safe
Confidence?65%Moderate
Short InterestModerate
Short % of Float?1.77%Low
Short Interest?21.8M
Days to Cover?3.4
Free Float1.2B
Avg Daily Volume6.5M
Settlement Date2026-09-30
Financial Health
Current Ratio?1.27Adequate
Quick Ratio?1.09Adequate
Cash Ratio?0.29Low
Debt/Equity?2.22High
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score53/100
P/E?N/A▾
P/B?16.10HIGH▾
Peers20
S&P10
P/S?6.25FAIR▾
Peers45
S&P20
P/FCF?14.7CHEAP▾
Peers89
S&P75
EV/EBITDA?66.1HIGH▾
Peers11
S&P3
EV/Sales?7.01HIGH▾
Peers55
S&P20
Returns & Efficiency
ROE?-27.4%WEAK▾
Peers13
S&P6
ROA?-6.6%WEAK▾
Peers11
S&P3
Cash Flow & Enterprise
FCF?$12.9B
Enterprise Value?$213.5B
Fundamentals ratios updated end of day